ArticleJournal of Korean medical science2026
Superior Efficacy of Besifovir in Reducing Hepatocellular Carcinoma Risk Compared to Tenofovir in Chronic Hepatitis B Patients: A Nationwide Cohort Study.
Yoon E Shin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.